WellBuilt
Designing an Oral Supplement That Activates GLP-1 | Cory Henderson, PhD, Co-founder & CEO of Evolve
49:51
On this episode of WellBuilt, Jon sits down with Cory Henderson PhD, Co-founder and CEO of Evolve, to unpack the science, hype, and real opportunity behind GLP-1 supplements—and why the next chapter of preventative health may look very different than pharmaceuticals.
Evolve isn't trying to compete with injectable GLP-1 drugs. Instead, the company is building a new category they calls…